- Home
- NVCR vs EVV Comparison
NVCR vs EVV Comparison
Compare NVCR & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- EVV
- Stock Information
- Founded
- NVCR 2000
- EVV 2003
- Country
- NVCR Switzerland
- EVV United States
- Employees
- NVCR N/A
- EVV N/A
- Industry
- NVCR Medical/Dental Instruments
- EVV Finance/Investors Services
- Sector
- NVCR Health Care
- EVV Finance
- Exchange
- NVCR Nasdaq
- EVV Nasdaq
- Market Cap
- NVCR 1.3B
- EVV 1.2B
- IPO Year
- NVCR 2015
- EVV N/A
- Fundamental
- Price
- NVCR $12.04
- EVV $9.99
- Analyst Decision
- NVCR Buy
- EVV
- Analyst Count
- NVCR 7
- EVV 0
- Target Price
- NVCR $28.64
- EVV N/A
- AVG Volume (30 Days)
- NVCR 1.7M
- EVV 323.7K
- Earning Date
- NVCR 10-30-2025
- EVV 01-01-0001
- Dividend Yield
- NVCR N/A
- EVV 9.66%
- EPS Growth
- NVCR N/A
- EVV N/A
- EPS
- NVCR N/A
- EVV N/A
- Revenue
- NVCR $642,269,000.00
- EVV N/A
- Revenue This Year
- NVCR $9.54
- EVV N/A
- Revenue Next Year
- NVCR $5.70
- EVV N/A
- P/E Ratio
- NVCR N/A
- EVV N/A
- Revenue Growth
- NVCR 11.17
- EVV N/A
- 52 Week Low
- NVCR $10.70
- EVV $8.52
- 52 Week High
- NVCR $34.13
- EVV $10.07
- Technical
- Relative Strength Index (RSI)
- NVCR 47.66
- EVV 45.69
- Support Level
- NVCR $11.09
- EVV $9.85
- Resistance Level
- NVCR $11.63
- EVV $10.00
- Average True Range (ATR)
- NVCR 0.52
- EVV 0.07
- MACD
- NVCR 0.05
- EVV -0.01
- Stochastic Oscillator
- NVCR 86.51
- EVV 50.00
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.